Comparative analysis of the human hepatic and adipose tissue transcriptomes during LPS-induced inflammation leads to the identification of differential biological pathways and candidate biomarkers

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Szalowska, Ewa ^a,c   Dijkstra, Martijn ^a   Elferink, Marieke Gl ^b   Weening, Desiree ^a   De Vries, Marcel ^a   Bruinenberg, Marcel ^a   Hoek, Annemieke ^a   Roelofsen, Han ^a   Groothuis, Geny Mm ^b   Vonk, Roel J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME; LIPOPOLYSACCHARIDE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; TISSUE CULTURE; TISSUE DIFFERENTIATION; UNINDEXED SEQUENCE; UPREGULATION; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CLUSTER ANALYSIS; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CELLS, CULTURED; CLUSTER ANALYSIS; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOPOLYSACCHARIDES; LIVER; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 80053553395     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-71     Document Type: Article

References (55)

1. Adipocytokines and the metabolic complications of obesity. Rasouli N, Kern PA, J Clin Endocrinol Metab 2008 93 64 S73 10.1210/jc.2008-1613 18987272
2. Inflammation and metabolic disorders. Hotamisligil GS, Nature 2006 444 860 867 10.1038/nature05485 17167474 (Pubitemid 46024993)
3. Inflammation and insulin resistance. Shoelson SE, Lee J, Goldfine AB, J Clin Invest 2006 116 1793 1801 10.1172/JCI29069 16823477
4. Inflammation, stress, and diabetes. Wellen KE, Hotamisligil GS, J Clin Invest 2005 115 1111 1119 15864338 (Pubitemid 40629025)
5. Robust signaling networks of the adipose secretome. Breitling R, Trends Endocrinol Metab 2009 20 1 7 10.1016/j.tem.2008.08.006 18930409
6. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T, FEBS J 2009 276 5747 5754 10.1111/j.1742-4658.2009.07304.x 19754872
7. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del GL, Elariny H, Van MA, Younoszai A, Goodman Z, Baranova A, et al. Liver Int 2005 25 760 771 10.1111/j.1478-3231.2005.01117.x 15998427 (Pubitemid 41038658)
8. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Edens MA, Kuipers F, Stolk RP, Obes Rev 2009 10 412 419 10.1111/j.1467-789X.2009.00594.x 19413701
9. Mechanisms of insulin resistance during acute endotoxemia. Virkamaki A, Yki-Jarvinen H, Endocrinology 1994 134 2072 2078 10.1210/en.134.5.2072 8156907 (Pubitemid 24142945)
10. Mechanisms of hepatic and peripheral insulin resistance during acute infections in humans. Virkamaki A, Puhakainen I, Koivisto VA, Vuorinen-Markkola H, Yki-Jarvinen H, J Clin Endocrinol Metab 1992 74 673 679 10.1210/jc.74.3.673 1740504
11. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, Tompkins RG, Martyn JA, Am J Physiol Endocrinol Metab 2002 282 386 E394 11788371
12. Insulin resistance and substrate utilization in human endotoxemia. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL, J Clin Endocrinol Metab 2000 85 3770 3778 10.1210/jc.85.10.3770 11061537
13. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A, Physiol Rev 2009 89 27 71 10.1152/physrev.00014.2008 19126754
14. Metabolic endotoxemia initiates obesity and insulin resistance. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Diabetes 2007 56 1761 1772 10.2337/db06-1491 17456850 (Pubitemid 47025442)
15. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, Groothuis GM, Am J Physiol Gastrointest Liver Physiol 2004 287 1008 G1016 10.1152/ajpgi.00071.2004 15205115 (Pubitemid 39423693)
16. Characterization of the human visceral adipose tissue secretome. Alvarez-Llamas G, Szalowska E, de Vries MP, Weening D, Landman K, Hoek A, Wolffenbuttel BH, Roelofsen H, Vonk RJ, Mol Cell Proteomics 2007 6 589 600 10.1074/mcp.M600265-MCP200 17255083 (Pubitemid 46630092)
17. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA, Genome Biol 2003 4 3 10.1186/gb-2003-4-5-p3
18. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Huang da W, Sherman BT, Lempicki RA, Nat Protoc 2009 4 44 57 19131956
19. STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et al. Nucleic Acids Res 2009 37 412 D416 10.1093/nar/gkn760 18940858
20. Feature-based prediction of non-classical and leaderless protein secretion. Bendtsen JD, Jensen LJ, Blom N, Von HG, Brunak S, Protein Eng Des Sel 2004 17 349 356 10.1093/protein/gzh037 15115854 (Pubitemid 39093515)
21. Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes. Roelofsen H, Dijkstra M, Weening D, de Vries MP, Hoek A, Vonk RJ, Mol Cell Proteomics 2009 8 316 324 18840871
22. Beyond standardization: dynamic software infrastructures for systems biology. Swertz MA, Jansen RC, Nat Rev Genet 2007 8 235 243 10.1038/nrg2048 17297480
23. Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP, Diabetes 2009
24. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT, Can J Physiol Pharmacol 2004 82 506 514 10.1139/y04-067 15389298 (Pubitemid 39388391)
25. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. She P, Van HC, Reid T, Hutson SM, Cooney RN, Lynch CJ, Am J Physiol Endocrinol Metab 2007 293 1552 E1563 10.1152/ajpendo.00134.2007 17925455 (Pubitemid 350255104)
26. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, et al. Nat Med 2009 15 930 939 10.1038/nm.2002 19633656
27. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, et al. Nat Med 2009 15 914 920 10.1038/nm.1964 19633658
28. Suppressors of cytokine signalling: SOCS. Larsen L, Ropke C, APMIS 2002 110 833 844 10.1034/j.1600-0463.2002.1101201.x 12645661 (Pubitemid 36177279)
29. SOCS proteins causing trouble in insulin action. Lebrun P, Van OE, Acta Physiol (Oxf) 2008 192 29 36 (Pubitemid 350265362)
30. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA, J Biol Chem 2003 278 13740 13746 10.1074/jbc.M210689200 12560330 (Pubitemid 36799910)
31. Obesity-related differential gene expression in the visceral adipose tissue. Baranova A, Collantes R, Gowder SJ, Elariny H, Schlauch K, Younoszai A, King S, Randhawa M, Pusulury S, Alsheddi T, et al. Obes Surg 2005 15 758 765 10.1381/0960892054222876 15978142 (Pubitemid 40904861)
32. Gene expression profile of omental adipose tissue in human obesity. Gomez-Ambrosi J, Catalan V, ez-Caballero A, Martinez-Cruz LA, Gil MJ, Garcia-Foncillas J, Cienfuegos JA, Salvador J, Mato JM, Fruhbeck G, FASEB J 2004 18 215 217 14630696
33. Inflammatory mechanisms in the regulation of insulin resistance. Tilg H, Moschen AR, Mol Med 2008 14 222 231 18235842 (Pubitemid 351481853)
34. Regulation of inflammation-related genes in human adipose tissue. Clement K, Langin D, J Intern Med 2007 262 422 430 10.1111/j.1365-2796.2007.01851.x 17875178 (Pubitemid 47404371)
35. Gene profiling of human adipose tissue during evoked inflammation in vivo. Shah R, Lu Y, Hinkle CC, McGillicuddy FC, Kim R, Hannenhalli S, Cappola TP, Heffron S, Wang X, Mehta NN, et al. Diabetes 2009 58 2211 2219 10.2337/db09-0256 19581417
36. Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ, Bogardus C, Permana PA, Diabetologia 2005 48 1784 1788 10.1007/s00125-005-1868-2 16034612 (Pubitemid 41317832)
37. Resistin is more abundant in liver than adipose tissue and is not upregulated by lipopolysaccharide. Szalowska E, Elferink MG, Hoek A, Groothuis GM, Vonk RJ, J Clin Endocrinol Metab 2009
38. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer. McIntyre E, Blackburn E, Brown PJ, Johnson CG, Gullick WJ, Breast Cancer Res Treat 2009
39. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. Commins S, Steinke JW, Borish L, J Allergy Clin Immunol 2008 121 1108 1111 10.1016/j.jaci.2008.02.026 18405958
40. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Sandona D, Betto R, Expert Rev Mol Med 2009 11 28 19781108
41. Metabolic disturbances in non-alcoholic fatty liver disease. Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH, Clin Sci (Lond) 2009 116 539 564 10.1042/CS20080253
42. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. Yilmaz Y, Ulukaya E, Atug O, Dolar E, Eur J Gastroenterol Hepatol 2009
43. The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. Pardo J, Aguilo JI, Anel A, Martin P, Joeckel L, Borner C, Wallich R, Mullbacher A, Froelich CJ, Simon MM, Microbes Infect 2009 11 452 459 10.1016/j.micinf.2009.02.004 19249384
44. Leukaemia inhibitory factor stimulates glucose transport in isolated cardiomyocytes and induces insulin resistance after chronic exposure. Florholmen G, Thoresen GH, Rustan AC, Jensen J, Christensen G, Aas V, Diabetologia 2006 49 724 731 10.1007/s00125-006-0150-6 16489447 (Pubitemid 43357546)
45. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. Dos Reis ST, Pontes J Jr, Villanova FE, Borra PM, Antunes AA, Dall'oglio MF, Srougi M, Leite KR, J Urol 2009 181 2320 2325 10.1016/j.juro.2009.01.012 19303106
46. Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas. Tetu B, Popa I, Bairati I, L'Esperance S, Bachvarova M, Plante M, Harel F, Bachvarov D, Mod Pathol 2008 21 1002 1010 10.1038/modpathol.2008.80 18500265
47. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, et al. PLoS Med 2008 5 93 10.1371/journal.pmed.0050093 18447576 (Pubitemid 351649261)
48. The Long Pentraxin 3 and Its Role in Autoimmunity. Ortega-Hernandez OD, Bassi N, Shoenfeld Y, Anaya JM, Semin Arthritis Rheum 2008
49. The long pentraxin PTX3 in vascular pathology. Mantovani A, Garlanda C, Bottazzi B, Peri G, Doni A, Martinez de la TY, Latini R, Vascul Pharmacol 2006 45 326 330 10.1016/j.vph.2006.08.011 17023219 (Pubitemid 44765293)
50. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome. Ogawa T, Kawano Y, Imamura T, Kawakita K, Sagara M, Matsuo T, Kakitsubata Y, Ishikawa T, Kitamura K, Hatakeyama K, et al. Obesity (Silver Spring) 2010 18 1871 1874 10.1038/oby.2009.507
51. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Zanetti M, Bosutti A, Ferreira C, Vinci P, Biolo G, Fonda M, Valente M, Cattin L, Guarnieri G, Barazzoni R, Clin Exp Med 2009 9 243 248 10.1007/s10238-009-0039-z 19238513
52. Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. Abderrahim-Ferkoune A, Bezy O, Chiellini C, Maffei M, Grimaldi P, Bonino F, Moustaid-Moussa N, Pasqualini F, Mantovani A, Ailhaud G, et al. J Lipid Res 2003 44 994 1000 10.1194/jlr.M200382-JLR200 12611905 (Pubitemid 37279659)
53. Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Shah R, Hinkle CC, Ferguson JF, Mehta NN, Li M, Qu L, Lu Y, Putt ME, Ahima RS, Reilly MP, Diabetes 2011 60 1512 1518 10.2337/db10-0956 21525510
54. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. Goldberg RB, J Clin Endocrinol Metab 2009 94 3171 3182 10.1210/jc.2008-2534 19509100
55. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Barnes M, Freudenberg J, Thompson S, Aronow B, Pavlidis P, Nucleic Acids Res 2005 33 5914 5923 10.1093/nar/gki890 16237126 (Pubitemid 41742611)